(Q45961306)

18 December 2017

title

Health care costs and their predictors of inflammatory bowel diseases in Germany. (English)

1 reference

18 December 2017

inflammatory bowel diseases

main subject

1 reference

Anne Prenzler

1

1 reference

18 December 2017

Bernd Bokemeyer

series ordinal

2

1 reference

18 December 2017

J-Matthias von der Schulenburg

series ordinal

3

1 reference

18 December 2017

Thomas Mittendorf

series ordinal

4

1 reference

18 December 2017

publication date

22 October 2010

1 reference

18 December 2017

The European Journal of Health Economics

published in

1 reference

18 December 2017

volume

12

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

273-283

1 reference

18 December 2017

Inflammatory bowel disease: clinical aspects and established and evolving therapies

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

[Costs of ambulant care for patients with inflammatory bowel disease in general practice]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Costs of inflammatory bowel disease in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Clinical practice guideline on diagnosis and treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

A comparison of multivariable regression models to analyse cost data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Parametric modelling of cost data in medical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Parametric modelling of cost data: some simulation evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

The direct and indirect cost burden of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Health care expenditures in ulcerative colitis: the perspective of a self-insured employer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

The costs of Crohn's disease in the United States and other Western countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

How expensive is inflammatory bowel disease? A critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-010-0281-Z

[Epidemiologic aspects of Crohn regional enterocolitis and ulcerative colitis in Marburg/Lahn (West Germany) between 1962 and 1975]

21 January 2018

1 reference

12 December 2020

Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study)

1 reference

12 December 2020

[Appraisal of resource use in the German health-care system from the perspective of the statutory health insurance]

1 reference

12 December 2020

[Cost measurement based on a cost diary in patients with inflammatory bowel disease]

1 reference

12 December 2020

Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany).

1 reference

12 December 2020

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

12 December 2020

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients

1 reference

12 December 2020

[Procedure of implementation of new methods of examination and treatment in the G-DRG system (NUB procedure)]

1 reference

12 December 2020

German recommendations on health economic evaluation: third and updated version of the Hanover Consensus

1 reference

12 December 2020

10.1007/S10198-010-0281-Z

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1046015498

0 references

1 reference

18 December 2017